Free Trial

Diversified Management Inc. Purchases 7,144 Shares of Danaher Corporation $DHR

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Diversified Management Inc. purchased 7,144 Danaher shares in the third quarter, valued at approximately $1.58 million. Institutional investors collectively own 79.05% of the company.
  • Analysts remain generally positive, with Danaher receiving a consensus rating of “Moderate Buy” and an average price target of $235.23; several firms recently set targets near $250.
  • Danaher reported quarterly EPS of $1.94, beating estimates of $1.85, while revenue rose 5.5% year over year to $6.26 billion. The company also announced a quarterly dividend of $0.40 per share, representing a 0.7% yield.
  • MarketBeat previews top five stocks to own in November.

Diversified Management Inc. purchased a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 7,144 shares of the conglomerate's stock, valued at approximately $1,583,000.

Other large investors also recently bought and sold shares of the company. Hilton Head Capital Partners LLC bought a new position in Danaher during the 4th quarter valued at about $27,000. Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate's stock worth $29,000 after acquiring an additional 53 shares during the period. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher in the second quarter worth $25,000. Main Street Group LTD purchased a new position in shares of Danaher in the first quarter worth approximately $25,000. Finally, Field & Main Bank purchased a new position in shares of Danaher during the 2nd quarter worth $29,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently weighed in on DHR shares. The Goldman Sachs Group lifted their target price on Danaher from $210.00 to $250.00 and gave the company a "buy" rating in a research report on Monday, September 21st. Wells Fargo & Company decreased their price objective on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 22nd. UBS Group assumed coverage on Danaher in a research report on Wednesday, September 9th. They set a "buy" rating and a $250.00 price objective on the stock. Royal Bank Of Canada boosted their price objective on Danaher from $215.00 to $250.00 and gave the company an "outperform" rating in a research note on Monday. Finally, TD Cowen dropped their target price on shares of Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $235.23.

Get Our Latest Report on Danaher

Danaher Trading Down 0.5%

DHR opened at $217.33 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market cap of $152.78 billion, a P/E ratio of 38.60, a P/E/G ratio of 2.72 and a beta of 0.76. The stock has a 50-day moving average of $210.88 and a 200 day moving average of $194.44.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the business earned $0.77 EPS. The business's revenue was up 5.5% on a year-over-year basis. As a group, research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher's payout ratio is currently 28.42%.

About Danaher

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines